Effective November 6, 2022, Alex Wylie resigned as Chief Financial Officer of Instadose Pharma Corp. and as Chief Financial Officer of its wholly owned Canadian subsidiary (Instadose Canada). Mr. Wylie will not hold any officer or director positions at the company or Instadose Canada following his resignation.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% | -.--% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 531 | |
+4.67% | 2.77B | |
-1.38% | 1.31B | |
+2.26% | 1.09B | |
+7.48% | 830M | |
+18.64% | 609M | |
-23.90% | 423M | |
-15.55% | 312M | |
-6.93% | 307M | |
+4.13% | 304M |
- Stock Market
- Equities
- INSD Stock
- News Instadose Pharma Corp.
- Instadose Pharma Corp. Announces Resignation of Alex Wylie as Chief Financial Officer